This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting neurological disorders, particularly those involving the modulation of neurotransmitter systems. Its specific structure, featuring a pyrrolidine ring and a tert-butyl carbamate group, makes it valuable for creating compounds with enhanced selectivity and potency. Additionally, it is employed in research settings to study receptor-ligand interactions and to develop novel therapeutic agents for conditions such as Parkinson’s disease, depression, and anxiety disorders. Its hydrochloride form ensures improved stability and solubility, facilitating its use in both laboratory and industrial processes.